Background. Congenital infections cause significant morbidity globally. In the United States, population studies have indicated that congenital infections disproportionately affect minorities and the economically disadvantaged. Through their chronic and disabling effects these infections perpetuate generational poverty among these groups. The objectives of this study were to (i) provide a national prevalence estimate of congenital infections in children 0-2 years using discharge diagnosis codes; (ii) compare risk of congenital infection between white and non-White children; and (iii) investigate the relationship between socioeconomic status and risk of congenital infection in the United States.
Group B Streptococcus
Background. Intrapartum antibiotic prophylaxis (IAP) prevents neonatal mortality from Group B Streptococcus (GBS). Clindamycin resistance among GBS isolates complicates IAP for GBS-positive women allergic to penicillin and cephalosporins. GBS screening by nucleic acid amplification tests (NAATs) provides rapid results, but no susceptibility data to inform IAP. We sought to estimate burden of clindamycin resistance among GBS in Los Angeles County (LAC).
Methods. Hospital antibiogram data were gathered from all LAC acute care hospitals from 2015 to 2016. Weighted averages for GBS resistance to clindamycin, erythromycin, penicillin, and TMP/SMX were calculated. Facilities which reported clindamycin susceptibilities were interviewed regarding antimicrobial susceptibility testing methods.
Results. A total of 2,339 GBS isolates from 22 hospitals were reported between 2015 and 2016. Thirteen hospitals tested GBS for clindamycin (nine reported in 2015 and 2016, four hospitals reported in 2016 only). Clindamycin resistance was found in 61.7% of 1,794 GBS isolates (79.3% of 891 in 2015, 44.3% of 903 in 2016). Erythromycin resistance was 42% in 735 isolates reported, 0.1% penicillin of 1,916 isolates reported, and 1.5% TMP/SMX of = 135 isolates reported. Facilities tested GBS by manual minimum inhibitory concentration (MIC) broth dilution (n = 1), automated MIC dilution (n = 4), agar plate diffusion (n = 1), and MIC dilution followed by agar plate diffusion (n = 1). Two hospitals did not perform testing on-site.
Conclusion. The 62% prevalence of clindamycin-resistant GBS in LAC is threefold higher than national CDC estimates and complicates IAP for GBS-positive women allergic to penicillin and cephalosporins. These data support CDC recommendations for susceptibility testing in addition to NAAT screening which does not include assays for common determinants of clindamycin resistance, erm-methylase, mef, and isa. There is an opportunity for diagnostic manufacturers and clinical labs to help clinicians choose appropriate IAP and prevent neonatal mortality. The CDC and public health should be aware of regional variations in clindamycin resistance. Clinicians should be aware of local resistance to inform IAP stewardship recommendations.
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The Effect of Prenatal Screening for Chlamydia trachomatis (CT) on Chlamydial Conjunctivitis in Infants
Methods. A retrospective, observational study of all infant eye samples submitted to the Chlamydia Research Laboratory at SUNY Downstate Medical Center for CT culture from 1986 to 2002. Culture results were divided into two groups by time period: pre-screening (1986-1993) and post-screening (1994-2002) .
Results. A total of 880 samples obtained from infants with signs and symptoms of conjunctivitis were submitted for CT culture, 103 (11.7%) were positive. The number of submitted samples and positive cultures both declined over time. The positivity rate for eye cultures was 15.6% during the pre-screening period (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) and was 1.8% during post-screening period (1994-2002) (P < 0.0001). A separate hospital audit confirmed >95% of pregnant women were screened during the post-screening period.
Conclusion. The prevalence of neonatal chlamydial conjunctivitis decreased significantly in our population after the implementation of routine screening and treatment of pregnant women in the United States in 1993.These results also confirm that the most effective way to prevent perinatal chlamydial infection is prenatal screening and treatment of pregnant women. These data have important implications for maternal and infant health globally.
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